Crisà, Elena http://orcid.org/0000-0003-1912-0574
Kulasekararaj, Austin G.
Adema, Vera
Such, Esperanza
Schanz, Julie
Haase, Detlef
Shirneshan, Katayoon
Best, Steven
Mian, Syed A
Kizilors, Aytug
Cervera, José
Lea, Nicholas
Ferrero, Dario
Germing, Ulrich
Hildebrandt, Barbara
Martínez, Ana Belén Valencia
Santini, Valeria
Sanz, Guillermo F. http://orcid.org/0000-0002-2767-8191
Solé, Francesc
Mufti, Ghulam J.
Article History
Received: 23 July 2019
Revised: 19 December 2019
Accepted: 28 January 2020
First Online: 17 February 2020
Compliance with ethical standards
:
: EC, AGK, VA, ES, JS, DH, KS, SB, SAM, AK, JC, NL, DF, UG, BH, ABVM, FS and GJM have no conflict of interests; VS has received honoraria from honoraria da Celgene, Novartis, Takeda, Amgen, Astex and Janssen; GFS has received honoraria from and/or played an advisory role for AbbVie, Amgen, Böehringer-Ingelheim, Celgene, Helsinn Healthcare and Hoffmann—La Roche, Janssen—Cilag and Novartis. GFS and ES work at Hospital Universitario y Politécnico La Fe, which receives research funding and/or participates in multiple clinical trials funded by different pharmaceutical companies, including AbbVie, Amgen, Böehringer-Ingelheim, Bristol-Myers Squibb, Celgene, Helsinn Healthcare and Hoffman—La Roche, Janssen—Cilag, Novartis and Onconova. GFS is also a member of the Spanish Group on Myelodysplastic Syndromes (Grupo Español de Síndromes Mielodisplásicos, GESMD), which is sponsored by Celgene and Novartis.